Michael Drummond

27.4k total citations · 7 hit papers
322 papers, 17.1k citations indexed

About

Michael Drummond is a scholar working on Economics and Econometrics, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Drummond has authored 322 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Economics and Econometrics, 96 papers in General Health Professions and 86 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Drummond's work include Health Systems, Economic Evaluations, Quality of Life (143 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (65 papers) and Healthcare Policy and Management (61 papers). Michael Drummond is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (143 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (65 papers) and Healthcare Policy and Management (61 papers). Michael Drummond collaborates with scholars based in United Kingdom, United States and Canada. Michael Drummond's co-authors include Tom Jefferson, Mark Sculpher, Robert A. Wise, Karl Claxton, Rosanna Tarricone, Corinna Sorenson, Federico Augustovski, Linda Davies, Andrea Manca and Bengt Jönsson and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Michael Drummond

305 papers receiving 16.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methods for the Economic Evaluation of Health Care Programmes

2005 2.7k citations Michael Drummond et al. profile →
Guidelines for authors and peer reviewers of economic submissions to the BMJ

1996 1.5k citations Michael Drummond et al. profile →
Decision Making in Health and Medicine: Integrating Evidence and Values

2001 502 citations Michael Drummond et al. profile →
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

2022 422 citations Don Husereau, Michael Drummond et al. Value in Health profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

2022 181 citations Don Husereau, Michael Drummond et al. profile →
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

2022 148 citations Don Husereau, Michael Drummond et al. profile →
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures

2023 103 citations Michael Drummond, Federico Augustovski et al. profile →

Peers

Countries citing papers authored by Michael Drummond

Since Specialization

Citations

This map shows the geographic impact of Michael Drummond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Drummond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Drummond more than expected).

Fields of papers citing papers by Michael Drummond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Drummond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Drummond. The network helps show where Michael Drummond may publish in the future.

Co-authorship network of co-authors of Michael Drummond

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Drummond. A scholar is included among the top collaborators of Michael Drummond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Drummond. Michael Drummond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Tezepelumab on Lung Function in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Grouped by Baseline Blood Eosinophil Count: Results From the Phase 2a COURSE Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Klaus F. Rabe, (unknown), Michael Drummond, (unknown), (unknown), (unknown), (unknown), Christopher S. Ambrose, Sandhia Ponnarambil	0
2	Association Between Airway Mucus Plugs and Risk of Moderate-to-Severe Exacerbations in Patients With COPD 2025 ·CHEST Journal ·(unknown), (unknown), Yuqiong Yang, (unknown), (unknown), Jiawei Chen, (unknown), Zizheng Chen, (unknown), (unknown), Wenqiang He, Zifei Zhou, Michael Drummond, Rongchang Chen, Fengyan Wang	3
3	Real-world evidence for coverage determination of treatments for rare diseases 2024 ·Orphanet Journal of Rare Diseases ·(unknown), Michael Drummond, Omar Dabbous, Mondher Toumi, Peter J. Neumann, Sean Tunis, (unknown), Shadi Saleh, Ulf Persson, Johann‐Matthias Graf von der Schulenburg, Daniel C. Malone, (unknown), Sean D. Sullivan	6
4	From Invisibility to Inclusion: A Call to Action to Address COPD Disparities in the Lesbian, Gay, Bisexual, Transgender, and Queer+ Community 2024 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·(unknown), Michael Drummond	2
5	Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers 2024 ·Expert Review of Pharmacoeconomics & Outcomes Research ·(unknown), (unknown), Jeonghoon Ahn, Iñaki Gutiérrez‐Ibarluzea, Michael Drummond, Steven Simoens, Zoltán Kaló, Dong‐Churl Suh	2
6	Colonoscopy vs the Fecal Immunochemical Test: Which is Best? 2024 ·Gastroenterology ·Douglas J. Robertson, Douglas K. Rex, Oriana Ciani, Michael Drummond	7
7	An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations 2023 ·Expert Review of Medical Devices ·Rosanna Tarricone, Helen Banks, Oriana Ciani, Werner Brouwer, Michael Drummond, Reiner Leidl, Nicolas Martelli, Laura Sampietro-Colom, Rod S Taylor	8
8	The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study 2023 ·Vaccines ·Manuela Di Fusco, Diana Mendes, Lotte Steuten, David E. Bloom, Michael Drummond, Katharina Hauck, Jonathan Pearson‐Stuttard, Rachel Power, David Salisbury, Adrian Towse, (unknown), Gábor Szabó, Jingyan Yang, (unknown)	7
9	Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease 2022 ·International Journal of COPD ·Jill Ohar, Gary T. Ferguson, Donald A. Mahler, Michael Drummond, Rajiv Dhand, Roy A. Pleasants, Antonio Anzueto, David Halpin, David Price, (unknown), Haley Hoy, John Haughney, (unknown), Omar S. Usmani	20
10	Association Between HIV and Prevalence and Manifestations of Asthma: Analysis of the Multicenter AIDS Cohort Study and Women's Interagency HIV Study 2022 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michael Drummond, Andrew Edmonds, Catalina Ramirez, Valentina Stosor, Igor Barjaktarević, Alison Morris, Meredith C. McCormack, Surya P. Bhatt, María L. Alcaide, Sushma K. Cribbs, Gypsyamber DʼSouza, (unknown), Ken M. Kunisaki, Laurence Huang, Seble Kassaye, Robert Foronjy, Anjali Sharma, Daniel Westreich, Adaora A. Adimora	1
11	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force breakdown → 2022 ·Value in Health ·Don Husereau, Michael Drummond, Federico Augustovski, Esther W. de Bekker‐Grob, Andrew Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh‐Fang Pwu, Sophie Staniszewska	422
12	Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 2020 ·Expert Review of Medical Devices ·Rosanna Tarricone, Oriana Ciani, Aleksandra Torbica, Werner Brouwer, (unknown), Michael Drummond, Nicolas Martelli, Ulf Persson, Reiner Leidl, (unknown), Laura Sampietro-Colom, Rod S Taylor	24
13	Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline 2020 ·American Journal of Respiratory and Critical Care Medicine ·Madalina Macrea, Simon Oczkowski, Bram Rochwerg, Richard D. Branson, Bartolomé R. Celli, John M. Coleman, Dean Hess, Shandra L. Knight, Jill Ohar, Jeremy E. Orr, Amanda J. Piper, Naresh M. Punjabi, Shilpa Rahangdale, Peter J. Wijkstra, Susie Yim‐Yeh, Michael Drummond, Robert L. Owens	99
14	A Cross Sectional Analysis of the Role of the Antimicrobial Peptide Cathelicidin in Lung Function Impairment within the ALIVE Cohort 2014 ·PLoS ONE ·Allison Lambert, Gregory D. Kirk, Jacquie Astemborski, Enid Neptune, Shruti H. Mehta, Robert A. Wise, Michael Drummond	16
15	Association between obstructive lung disease and markers of HIV infection in a high-risk cohort 2011 ·Thorax ·Michael Drummond, Gregory D. Kirk, Jacquie Astemborski, (unknown), Shruti H. Mehta, John F. McDyer, Robert H. Brown, Robert A. Wise, Christian A. Merlo	74
16	Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability 2005 ·Value in Health ·Marco Barbieri, Michael Drummond, Richard J. Willke, J Chancellor, (unknown), Adrian Towse	97
17	Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness? 2002 ·PubMed ·Michael Drummond	6
18	Assessing the cost effectiveness of NSAID: an international perspective. 1995 ·PubMed ·Michael Drummond, Marcos Bosi Ferraz, James Mason	11
19	Part II (continued)--financing health care. 1982 ·BMJ ·Michael Drummond, Graham Mooney	1
20	Economic appraisal in health care: 1. A guide to the methodology of economic appraisal. 1981 ·PubMed ·Michael Drummond, Graham Mooney	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact